Tezspire 210 mg solution for injection in pre-filled pen

*
Pharmacy Only: Prescription
  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

qrcode image

Scan the QR code or enter an email to access and share this medicine:

Updated on 08 August 2025

File name

20250725 Package Leaflet IE MT Tezspire PFP 210mg Add SBC and IFU Updates RSP 25 0004.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder

Free text change information supplied by the pharmaceutical company

Addition of IFU to the PIL.

Updated on 08 August 2025

File name

20250725 Package Leaflet IE MT Tezspire PFP 210mg Add SBC and IFU Updates RSP 25 0004.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder

Free text change information supplied by the pharmaceutical company

Addition to IFU to the leaflet

Updated on 14 March 2024

File name

20230921 Package Leaflet IE MT Tezspire PFP 210mg Postcode Update RSP 23 0018.pdf

Reasons for updating

  • New PIL for new product

Updated on 14 March 2024

File name

20230915 SPC IE MT Tezspire PFP PFS 210mg Anaphylaxis PRAC RSP 23 0012.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

AstraZeneca Pharmaceuticals (Ireland) DAC

AstraZeneca Pharmaceuticals (Ireland) DAC